Bausch + Lomb (BLCO) total debt

Total debt · fiscal 2025
$5.08B

Bausch + Lomb (BLCO) carried total debt of $5.08B at the end of fiscal 2025 (December 31, 2025). That is 6.2% higher than the $4.78B of fiscal 2024. Figures as of 18 Nov 2026, 07:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$5.08B
Change on fiscal 2024
+6.2%
Highest on record
$5.08Bfiscal 2025
Lowest on record
$0.00fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bausch + Lomb total debt, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $5.08B in fiscal 2025 and the lowest $0.00 in fiscal 2021.

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

History · 5 fiscal years

Total debt by fiscal year

Bausch + Lomb total debt, year by year

Bausch + Lomb (BLCO) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$5.08B 6.2% up0.8×
2024$4.78B 4.9% up0.7×
2023$4.56B 87.3% up0.7×
2022$2.44B—0.3×
2021$0.00—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Bausch + Lomb and comparable companies
CompanyTotal debtFiscal year
ImmunityBio IBRX$518.08M2025
Cytokinetics CYTK$1.28B2025
ABIVAX ABVX€1.86M2025
Bausch + Lomb BLCO$5.08B2025
Amneal Pharmaceuticals AMRX$2.69B2025
Caris Life Sciences CAI$427.69M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLCO

Bausch + Lomb, figure by figure

Bausch + Lomb (BLCO) overview: price, valuation and scorecardAll health care companies by market value

Bausch + Lomb total debt: questions and answers

How much debt does Bausch + Lomb have?

Bausch + Lomb (BLCO) carried total debt of $5.08B at the end of fiscal 2025 (December 31, 2025). That is 6.2% higher than the $4.78B of fiscal 2024.

What are the highest and lowest total debt figures on record for Bausch + Lomb?

Across the 5 fiscal years on record (2021–2025), the highest was $5.08B in fiscal 2025 and the lowest $0.00 in fiscal 2021.

How does Bausch + Lomb's debt compare with its equity?

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

How is Bausch + Lomb's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bausch + Lomb (BLCO) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/BLCO/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.